Drug Profile
DA 7010
Alternative Names: DA-7010Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Dong-A ST
- Class Antibacterials
- Mechanism of Action Leucyl-tRNA synthetase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Bacterial-infections in South Korea (IV)
- 28 May 2021 No recent reports of development identified for preclinical development in Bacterial-infections in South Korea (PO)
- 22 Apr 2017 Preclinical trials in Bacterial infections in South Korea (IV) before April 2017